We provide you with 20 years of free, institutional-grade data for ABBV stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ABBV. Explore the full financial landscape of ABBV stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$11,043,055
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| SALEKI-GERHARDT AZITA | Sale | -42,370 | $198.42 | $8,407,055 | 2025-08-14 |
| SALEKI-GERHARDT AZITA | Derivatives Exercise | 42,370 | 2025-08-14 | ||
| Donoghoe Nicholas | Sale | -13,295 | $198.27 | $2,636,000 | 2025-08-07 |
| AbbVie Inc. | Initial | 2025-07-11 | |||
| Roberts Rebecca B | Grant, award...etc | 1,203 | 2025-05-13 | ||
| Quaggin Susan E | Grant, award...etc | 1,203 | 2025-05-13 | ||
| MEYER MELODY B | Grant, award...etc | 1,203 | 2025-05-13 | ||
| Davis Jennifer L. | Grant, award...etc | 1,203 | 2025-05-13 | ||
| Hart Brett J | Grant, award...etc | 1,203 | 2025-05-13 | ||
| AUSTIN ROXANNE S | Grant, award...etc | 1,203 | 2025-05-13 | ||
| BURNSIDE WILLIAM H.L. | Grant, award...etc | 1,203 | 2025-05-13 | ||
| Alpern Robert J | Grant, award...etc | 1,203 | 2025-05-13 | ||
| FALK THOMAS J | Initial | 2025-05-13 | |||
| RAPP EDWARD J | Grant, award...etc | 1,203 | 2025-05-13 | ||
| WADDELL FREDERICK H | Grant, award...etc | 1,203 | 2025-05-13 | ||
| TILTON GLENN F | Grant, award...etc | 1,203 | 2025-05-13 | ||
| FALK THOMAS J | Grant, award...etc | 1,203 | 2025-05-13 | ||
| FREYMAN THOMAS C | Grant, award...etc | 1,203 | 2025-05-13 | ||
| Stewart Jeffrey Ryan | Sale | -58,832 | $209.49 | $12,324,716 | 2025-04-02 |
| Stewart Jeffrey Ryan | Derivatives Exercise | 25,700 | 2025-04-02 | ||
| Reents Scott T | Sale | -17,644 | $212.34 | $3,746,527 | 2025-03-18 |
| Purdue David Ryan | Initial | 2025-03-10 | |||
| Reents Scott T | Sale | -10,973 | $205.02 | $2,249,684 | 2025-03-04 |
| Michael Robert A. | Sale | -27,186 | $205.02 | $5,573,674 | 2025-03-04 |
| SALEKI-GERHARDT AZITA | Sale | -17,056 | $205.02 | $3,496,821 | 2025-03-04 |
| Stewart Jeffrey Ryan | Sale | -20,226 | $205.02 | $4,146,735 | 2025-03-04 |
| Siatis Perry C | Derivatives Exercise | 18,008 | 2025-03-04 | ||
| Siatis Perry C | Sale | -35,770 | $205.02 | $7,333,565 | 2025-03-04 |
| RICHMOND TIMOTHY J. | Sale | -38,154 | $205.02 | $7,822,333 | 2025-03-04 |
| Buckbee Kevin K | Sale | -3,699 | $205.02 | $758,369 | 2025-03-04 |
| Thakkar Roopal | Sale | -4,678 | $205.02 | $959,084 | 2025-03-04 |
| Donoghoe Nicholas | Sale | -11,230 | $205.02 | $2,302,375 | 2025-03-04 |
| GONZALEZ RICHARD A | Sale | -171,837 | $205.02 | $35,230,022 | 2025-03-04 |
| Buckbee Kevin K | Derivatives Exercise | 16,260 | 2025-02-28 | ||
| Buckbee Kevin K | Sale | -18,944 | $203.4 | $3,853,210 | 2025-02-28 |
| RICHMOND TIMOTHY J. | Derivatives Exercise | 22,210 | 2025-02-28 | ||
| RICHMOND TIMOTHY J. | Sale | -29,917 | $202.06 | $6,045,029 | 2025-02-28 |
| Siatis Perry C | Sale | -5,778 | $197.4 | $1,140,577 | 2025-02-24 |
| Buckbee Kevin K | Grant, award...etc | 8,347 | 2025-02-18 | ||
| Thakkar Roopal | Grant, award...etc | 10,555 | 2025-02-18 | ||
| Stewart Jeffrey Ryan | Grant, award...etc | 45,651 | 2025-02-18 | ||
| Siatis Perry C | Grant, award...etc | 17,762 | 2025-02-18 | ||
| SALEKI-GERHARDT AZITA | Grant, award...etc | 38,498 | 2025-02-18 | ||
| Reents Scott T | Grant, award...etc | 24,763 | 2025-02-18 | ||
| RICHMOND TIMOTHY J. | Grant, award...etc | 38,154 | 2025-02-18 | ||
| Donoghoe Nicholas | Grant, award...etc | 25,345 | 2025-02-18 | ||
| Michael Robert A. | Grant, award...etc | 61,362 | 2025-02-18 | ||
| GONZALEZ RICHARD A | Grant, award...etc | 171,837 | 2025-02-18 | ||
| Thakkar Roopal | Grant, award...etc | 11,088 | 2025-02-07 | ||
| Buckbee Kevin K | Sale | -1,800 | $172.24 | $310,032 | 2024-12-18 |
| Buckbee Kevin K | Derivatives Exercise | 1,800 | 2024-12-18 | ||
| GONZALEZ RICHARD A | Sale | -66,500 | $186.52 | $12,403,580 | 2024-08-07 |
| GONZALEZ RICHARD A | Sale | -282,845 | $175 | $49,497,875 | 2024-07-19 |
| GONZALEZ RICHARD A | Derivatives Exercise | 282,845 | 2024-07-19 | ||
| Alpern Robert J | Grant, award...etc | 1,322 | 2024-05-07 | ||
| FREYMAN THOMAS C | Grant, award...etc | 1,322 | 2024-05-07 | ||
| Hart Brett J | Grant, award...etc | 1,322 | 2024-05-07 | ||
| AUSTIN ROXANNE S | Grant, award...etc | 1,322 | 2024-05-07 | ||
| Roberts Rebecca B | Grant, award...etc | 1,322 | 2024-05-07 | ||
| MEYER MELODY B | Grant, award...etc | 1,322 | 2024-05-07 | ||
| BURNSIDE WILLIAM H.L. | Grant, award...etc | 1,322 | 2024-05-07 | ||
| WADDELL FREDERICK H | Grant, award...etc | 1,322 | 2024-05-07 | ||
| TILTON GLENN F | Grant, award...etc | 1,322 | 2024-05-07 | ||
| Davis Jennifer L. | Grant, award...etc | 1,322 | 2024-05-07 | ||
| Quaggin Susan E | Grant, award...etc | 1,322 | 2024-05-07 | ||
| RAPP EDWARD J | Grant, award...etc | 1,322 | 2024-05-07 | ||
| Donoghoe Nicholas | Sale | -21,082 | $176.3 | $3,716,757 | 2024-03-22 |
| Stewart Jeffrey Ryan | Sale | -58,949 | $178.85 | $10,543,029 | 2024-03-20 |
| Stewart Jeffrey Ryan | Derivatives Exercise | 26,110 | 2024-03-20 | ||
| RICHMOND TIMOTHY J. | Sale | -75,680 | $176.4 | $13,349,952 | 2024-03-05 |
| RICHMOND TIMOTHY J. | Derivatives Exercise | 45,700 | 2024-03-05 | ||
| Buckbee Kevin K | Sale | -10,483 | $178.99 | $1,876,352 | 2024-03-01 |
| Michael Robert A. | Derivatives Exercise | 21,560 | 2024-03-01 | ||
| Michael Robert A. | Sale | -106,517 | $178.99 | $19,065,478 | 2024-03-01 |
| Siatis Perry C | Sale | -17,776 | $178.99 | $3,181,726 | 2024-03-01 |
| Stewart Jeffrey Ryan | Sale | -26,121 | $178.99 | $4,675,398 | 2024-03-01 |
| SALEKI-GERHARDT AZITA | Sale | -23,966 | $178.99 | $4,289,674 | 2024-03-01 |
| Hudson Thomas J | Sale | -20,634 | $178.99 | $3,693,280 | 2024-03-01 |
| RICHMOND TIMOTHY J. | Sale | -23,847 | $178.99 | $4,268,375 | 2024-03-01 |
| Thakkar Roopal | Sale | -4,914 | $178.99 | $879,557 | 2024-03-01 |
| GONZALEZ RICHARD A | Sale | -248,865 | $178.99 | $44,544,346 | 2024-03-01 |
| Donoghoe Nicholas | Sale | -16,771 | $178.99 | $3,001,841 | 2024-03-01 |
| Reents Scott T | Sale | -25,774 | $177.44 | $4,573,339 | 2024-03-01 |
| Reents Scott T | Derivatives Exercise | 14,140 | 2024-03-01 | ||
| Siatis Perry C | Sale | -13,753 | $177.51 | $2,441,295 | 2024-02-27 |
| Siatis Perry C | Derivatives Exercise | 13,753 | 2024-02-27 | ||
| SALEKI-GERHARDT AZITA | Sale | -52,870 | $173.71 | $9,184,048 | 2024-02-23 |
| SALEKI-GERHARDT AZITA | Derivatives Exercise | 52,870 | 2024-02-23 | ||
| Michael Robert A. | Grant, award...etc | 84,957 | 2024-02-20 | ||
| Reents Scott T | Grant, award...etc | 26,256 | 2024-02-20 | ||
| GONZALEZ RICHARD A | Grant, award...etc | 248,865 | 2024-02-20 | ||
| Hudson Thomas J | Grant, award...etc | 46,572 | 2024-02-20 | ||
| Stewart Jeffrey Ryan | Grant, award...etc | 58,960 | 2024-02-20 | ||
| SALEKI-GERHARDT AZITA | Grant, award...etc | 54,095 | 2024-02-20 | ||
| RICHMOND TIMOTHY J. | Grant, award...etc | 53,827 | 2024-02-20 | ||
| Donoghoe Nicholas | Grant, award...etc | 37,853 | 2024-02-20 | ||
| Buckbee Kevin K | Grant, award...etc | 12,048 | 2024-02-20 | ||
| Siatis Perry C | Grant, award...etc | 17,796 | 2024-02-20 | ||
| Thakkar Roopal | Grant, award...etc | 17,796 | 2024-02-20 |
The information provided in this report about ABBV stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
AbbVie Inc(NYSE:ABBV) 
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the...
Website: http://www.abbvie.com
Founded: 2013
Full Time Employees: 50,000 (Dec 2022)
CEO: Richard Gonzalez
Sector: Healthcare
Industry: Drug Manufacturers-General
